Galderma stock pre-market at EUR 205.50: dermatology group
Published on 10/27/2026 at 07:40 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWSDermatology business and market context
- Galderma develops products and services across injectable aesthetics, dermatological skincare and therapeutic dermatology.
- The home market is Switzerlandâs SMI.
- Galderma stock trades pre-market at EUR 205.50 at 7:36 a.m. CEST at Lang & Schwarz on October 27, 2026.
Galderma develops products and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology, according to the companyâs April 22, 2026 company release. Galderma stock trades pre-market at EUR 205.50 at 7:36 a.m. CEST at Lang & Schwarz on October 27, 2026.
Ahead of the Xetra open
Lang & Schwarz recorded a bid of EUR 204.70 and an ask of EUR 206.30. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Galderma stock.
The group and its market
Galderma earns revenue from a dermatology portfolio spanning injectable aesthetics, dermatological skincare and therapeutic dermatology. The company is listed on SIX Swiss Exchange, making Switzerlandâs SMI the relevant benchmark market for this report.
Market context: Market report SMI.
